# ABSORB Clinical Investigation, Cohort B

> **NCT00856856** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 101 (actual)

## Conditions studied

- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis

## Interventions

- **DEVICE:** Bioabsorbable Everolimus Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00856856
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2015-10
- **Final completion:** 2016-03
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856856, "ABSORB Clinical Investigation, Cohort B". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00856856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*